Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2003-03-07
2009-12-08
Zeman, Robert A (Department: 1645)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S054000, C424S278100, C424S280100
Reexamination Certificate
active
07629313
ABSTRACT:
Provided are natural and synthetic immunomodulatory polymeric antigens (SPAs), compositions containing SPAs, and methods of using these natural and synthetic SPAs and compositions to prevent or treat inflammatory pathologies.
REFERENCES:
patent: WO/0059515 (2000-10-01), None
Freshney (Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York).
Dermer (Bio/Technology, 1994, vol. 12 p. 320).
Tzianabos A. O., et al.,Journal of Biological Chemistry, vol. 275, No. 10, Mar. 10, 2000, pp. 6733-6740; “T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria”.
International Search Report for WO 03/075953.
Rosenthal, Raoul and Roman Dziarski, “Isolation of Peptidoglycan and Soluble Peptidoglycan Fragments”, Methods in Enzymology, Academic Press, Inc., 235:253-285 (1994).
Blackburn Neil Thomas
Blaszczak Larry Chris
Taylor Kathleen Ann
Eli Lilly and Company
Maher David W.
Tech Law LLP
Zeman Robert A
LandOfFree
Immunomodulatory polymeric antigens for treating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunomodulatory polymeric antigens for treating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunomodulatory polymeric antigens for treating... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4149000